• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021

    12/10/21 12:41:31 PM ET
    $ABT
    $AGCO
    $APP
    $ARNC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Industrials
    Get the next $ABT alert in real time by email

     

    Upgrades

    • According to JP Morgan, the prior rating for Arconic Corp (NYSE:ARNC) was changed from Neutral to Overweight. In the third quarter, Arconic showed an EPS of $0.15, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $38.49 and a 52-week-low of $21.80. At the end of the last trading period, Arconic closed at $29.84.
    • HSBC upgraded the previous rating for LyondellBasell Industries NV (NYSE:LYB) from Hold to Buy. For the third quarter, LyondellBasell Industries had an EPS of $5.25, compared to year-ago quarter EPS of $1.27. The current stock performance of LyondellBasell Industries shows a 52-week-high of $118.02 and a 52-week-low of $84.06. Moreover, at the end of the last trading period, the closing price was at $89.95.
    • For Twilio Inc (NYSE:TWLO), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the third quarter, Twilio had an EPS of $0.01, compared to year-ago quarter EPS of $0.04. The current stock performance of Twilio shows a 52-week-high of $457.30 and a 52-week-low of $235.00. Moreover, at the end of the last trading period, the closing price was at $268.29.
    • Stephens & Co. upgraded the previous rating for Greenbrier Companies Inc (NYSE:GBX) from Equal-Weight to Overweight. Greenbrier Companies earned $0.98 in the fourth quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Greenbrier Companies shows a 52-week-high of $50.21 and a 52-week-low of $33.29. Moreover, at the end of the last trading period, the closing price was at $42.27.
    • For Patterson-UTI Energy Inc (NASDAQ:PTEN), Citigroup upgraded the previous rating of Neutral to Buy. In the third quarter, Patterson-UTI Energy showed an EPS of $0.44, compared to $0.60 from the year-ago quarter. The current stock performance of Patterson-UTI Energy shows a 52-week-high of $11.27 and a 52-week-low of $4.98. Moreover, at the end of the last trading period, the closing price was at $8.45.
    • According to Truist Securities, the prior rating for Martin Marietta Materials Inc (NYSE:MLM) was changed from Hold to Buy. Martin Marietta Materials earned $4.25 in the third quarter, compared to $3.84 in the year-ago quarter. The current stock performance of Martin Marietta Materials shows a 52-week-high of $435.62 and a 52-week-low of $258.18. Moreover, at the end of the last trading period, the closing price was at $427.29.
    • According to Oppenheimer, the prior rating for Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) was changed from Perform to Outperform. For the third quarter, Aurinia Pharmaceuticals had an EPS of $0.39, compared to year-ago quarter EPS of $0.28. The current stock performance of Aurinia Pharmaceuticals shows a 52-week-high of $33.97 and a 52-week-low of $9.72. Moreover, at the end of the last trading period, the closing price was at $20.97.
    • According to Deutsche Bank, the prior rating for Oracle Corp (NYSE:ORCL) was changed from Hold to Buy. In the second quarter, Oracle showed an EPS of $1.21, compared to $1.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $98.95 and a 52-week-low of $58.80. Oracle closed at $88.77 at the end of the last trading period.
    • According to JP Morgan, the prior rating for Sprinklr Inc (NYSE:CXM) was changed from Neutral to Overweight. For the third quarter, Sprinklr had an EPS of $0.06, compared to year-ago quarter EPS of $0.02. The current stock performance of Sprinklr shows a 52-week-high of $26.50 and a 52-week-low of $12.12. Moreover, at the end of the last trading period, the closing price was at $13.51.
    • Cowen & Co. upgraded the previous rating for SM Energy Co (NYSE:SM) from Market Perform to Outperform. In the third quarter, SM Energy showed an EPS of $0.74, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $38.25 and a 52-week-low of $5.06. At the end of the last trading period, SM Energy closed at $31.54.
    • For Royal Caribbean Group (NYSE:RCL), Berenberg upgraded the previous rating of Sell to Hold. For the third quarter, Royal Caribbean Gr had an EPS of $4.91, compared to year-ago quarter EPS of $5.62. At the moment, the stock has a 52-week-high of $99.24 and a 52-week-low of $64.20. Royal Caribbean Gr closed at $74.70 at the end of the last trading period.
    • For Zymeworks Inc (NYSE:ZYME), SVB Leerink upgraded the previous rating of Market Perform to Outperform. In the third quarter, Zymeworks showed an EPS of $1.25, compared to $1.43 from the year-ago quarter. The stock has a 52-week-high of $59.03 and a 52-week-low of $16.02. At the end of the last trading period, Zymeworks closed at $16.12.
    • According to JP Morgan, the prior rating for Bright Health Group Inc (NYSE:BHG) was changed from Neutral to Overweight. Bright Health Gr earned $0.48 in the third quarter, compared to $0.43 in the year-ago quarter. The current stock performance of Bright Health Gr shows a 52-week-high of $17.93 and a 52-week-low of $3.07. Moreover, at the end of the last trading period, the closing price was at $4.35.
    • For Commercial Metals Co (NYSE:CMC), JP Morgan upgraded the previous rating of Neutral to Overweight. For the fourth quarter, Commercial Metals had an EPS of $1.26, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $36.86 and a 52-week-low of $19.44. At the end of the last trading period, Commercial Metals closed at $33.04.
    • For AvalonBay Communities Inc (NYSE:AVB), BMO Capital upgraded the previous rating of Market Perform to Outperform. AvalonBay Communities earned $2.06 in the third quarter, compared to $2.06 in the year-ago quarter. The stock has a 52-week-high of $247.45 and a 52-week-low of $154.84. At the end of the last trading period, AvalonBay Communities closed at $242.52.
    • Goldman Sachs upgraded the previous rating for Jabil Inc (NYSE:JBL) from Neutral to Buy. Jabil earned $1.44 in the fourth quarter, compared to $0.98 in the year-ago quarter. The current stock performance of Jabil shows a 52-week-high of $65.79 and a 52-week-low of $39.06. Moreover, at the end of the last trading period, the closing price was at $61.72.

    See all analyst ratings upgrades.

     

    Downgrades

    • According to Northland Capital Markets, the prior rating for Everbridge Inc (NASDAQ:EVBG) was changed from Outperform to Market Perform. In the third quarter, Everbridge showed an EPS of $0.05, compared to $0.05 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of $178.98 and a 52-week-low of $103.28. Moreover, at the end of the last trading period, the closing price was at $115.37.
    • Evercore ISI Group downgraded the previous rating for Fidelity National Information Services Inc (NYSE:FIS) from Outperform to In-Line. Fidelity National Info earned $1.73 in the third quarter, compared to $1.42 in the year-ago quarter. The current stock performance of Fidelity National Info shows a 52-week-high of $155.96 and a 52-week-low of $101.79. Moreover, at the end of the last trading period, the closing price was at $104.99.
    • Morgan Stanley downgraded the previous rating for Radius Health Inc (NASDAQ:RDUS) from Equal-Weight to Underweight. In the third quarter, Radius Health showed an EPS of $0.32, compared to $0.15 from the year-ago quarter. The current stock performance of Radius Health shows a 52-week-high of $26.16 and a 52-week-low of $7.39. Moreover, at the end of the last trading period, the closing price was at $7.60.
    • For Zymeworks Inc (NYSE:ZYME), Raymond James downgraded the previous rating of Strong Buy to Outperform. In the third quarter, Zymeworks showed an EPS of $1.25, compared to $1.43 from the year-ago quarter. The stock has a 52-week-high of $59.03 and a 52-week-low of $16.02. At the end of the last trading period, Zymeworks closed at $16.12.
    • According to Morgan Stanley, the prior rating for Torrid Holdings Inc (NYSE:CURV) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of $33.19 and a 52-week-low of $11.10. At the end of the last trading period, Torrid Holdings closed at $11.28.
    • Needham downgraded the previous rating for Everbridge Inc (NASDAQ:EVBG) from Buy to Hold. Everbridge earned $0.05 in the third quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $178.98 and a 52-week-low of $103.28. At the end of the last trading period, Everbridge closed at $115.37.
    • For Global Payments Inc (NYSE:GPN), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. For the third quarter, Global Payments had an EPS of $2.18, compared to year-ago quarter EPS of $1.71. The stock has a 52-week-high of $220.81 and a 52-week-low of $116.75. At the end of the last trading period, Global Payments closed at $127.37.
    • According to Evercore ISI Group, the prior rating for Fiserv Inc (NASDAQ:FISV) was changed from Outperform to In-Line. For the third quarter, Fiserv had an EPS of $1.47, compared to year-ago quarter EPS of $1.20. At the moment, the stock has a 52-week-high of $127.34 and a 52-week-low of $92.06. Fiserv closed at $103.53 at the end of the last trading period.
    • For Mesa Air Group Inc (NASDAQ:MESA), Deutsche Bank downgraded the previous rating of Buy to Hold. Mesa Air Group earned $0.06 in the fourth quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Mesa Air Group shows a 52-week-high of $17.40 and a 52-week-low of $6.02. Moreover, at the end of the last trading period, the closing price was at $7.08.
    • According to Berenberg, the prior rating for Mimecast Ltd (NASDAQ:MIME) was changed from Buy to Hold. Mimecast earned $0.40 in the second quarter, compared to $0.32 in the year-ago quarter. The current stock performance of Mimecast shows a 52-week-high of $85.48 and a 52-week-low of $38.84. Moreover, at the end of the last trading period, the closing price was at $79.19.
    • According to Berenberg, the prior rating for Sumo Logic Inc (NASDAQ:SUMO) was changed from Buy to Hold. Sumo Logic earned $0.12 in the third quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Sumo Logic shows a 52-week-high of $46.37 and a 52-week-low of $12.90. Moreover, at the end of the last trading period, the closing price was at $14.25.
    • B of A Securities downgraded the previous rating for Everbridge Inc (NASDAQ:EVBG) from Neutral to Underperform. Everbridge earned $0.05 in the third quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $178.98 and a 52-week-low of $103.28. At the end of the last trading period, Everbridge closed at $115.37.
    • For Southwest Airlines Co (NYSE:LUV), Goldman Sachs downgraded the previous rating of Neutral to Sell. In the third quarter, Southwest Airlines showed an EPS of $0.23, compared to $1.99 from the year-ago quarter. The current stock performance of Southwest Airlines shows a 52-week-high of $64.75 and a 52-week-low of $42.39. Moreover, at the end of the last trading period, the closing price was at $43.61.
    • According to Credit Suisse, the prior rating for Peloton Interactive Inc (NASDAQ:PTON) was changed from Outperform to Neutral. In the first quarter, Peloton Interactive showed an EPS of $1.25, compared to $0.20 from the year-ago quarter. The current stock performance of Peloton Interactive shows a 52-week-high of $171.09 and a 52-week-low of $40.27. Moreover, at the end of the last trading period, the closing price was at $40.70.
    • JP Morgan downgraded the previous rating for Constellium SE (NYSE:CSTM) from Overweight to Neutral. Constellium earned $0.77 in the third quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.59 and a 52-week-low of $11.92. Constellium closed at $17.66 at the end of the last trading period.
    • JP Morgan downgraded the previous rating for Kaiser Aluminum Corp (NASDAQ:KALU) from Neutral to Underweight. In the third quarter, Kaiser Aluminum showed an EPS of $0.57, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $141.07 and a 52-week-low of $84.78. Kaiser Aluminum closed at $96.92 at the end of the last trading period.
    • According to Wedbush, the prior rating for BJ's Restaurants Inc (NASDAQ:BJRI) was changed from Outperform to Neutral. In the third quarter, BJ's Restaurants showed an EPS of $0.13, compared to $0.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $63.42 and a 52-week-low of $28.85. BJ's Restaurants closed at $36.20 at the end of the last trading period.
    • For Everbridge Inc (NASDAQ:EVBG), Barclays downgraded the previous rating of Overweight to Equal-Weight. In the third quarter, Everbridge showed an EPS of $0.05, compared to $0.05 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of $178.98 and a 52-week-low of $103.28. Moreover, at the end of the last trading period, the closing price was at $115.37.
    • Stifel downgraded the previous rating for Everbridge Inc (NASDAQ:EVBG) from Buy to Hold. For the third quarter, Everbridge had an EPS of $0.05, compared to year-ago quarter EPS of $0.05. The stock has a 52-week-high of $178.98 and a 52-week-low of $103.28. At the end of the last trading period, Everbridge closed at $115.37.
    • According to Baird, the prior rating for Everbridge Inc (NASDAQ:EVBG) was changed from Outperform to Neutral. In the third quarter, Everbridge showed an EPS of $0.05, compared to $0.05 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of $178.98 and a 52-week-low of $103.28. Moreover, at the end of the last trading period, the closing price was at $115.37.
    • According to JP Morgan, the prior rating for Everbridge Inc (NASDAQ:EVBG) was changed from Overweight to Neutral. Everbridge earned $0.05 in the third quarter, compared to $0.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $178.98 and a 52-week-low of $103.28. Everbridge closed at $115.37 at the end of the last trading period.
    • JP Morgan downgraded the previous rating for B2Gold Corp (AMEX:BTG) from Neutral to Underweight. For the third quarter, B2Gold had an EPS of $0.12, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $6.04 and a 52-week-low of $3.30. B2Gold closed at $3.73 at the end of the last trading period.
    • For Centerspace (NYSE:CSR), BMO Capital downgraded the previous rating of Outperform to Market Perform. In the third quarter, Centerspace showed an EPS of $0.98, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $111.73 and a 52-week-low of $66.91. At the end of the last trading period, Centerspace closed at $108.75.
    • Deutsche Bank downgraded the previous rating for Carrier Global Corp (NYSE:CARR) from Buy to Hold. Carrier Global earned $0.71 in the third quarter, compared to $0.67 in the year-ago quarter. The current stock performance of Carrier Global shows a 52-week-high of $58.89 and a 52-week-low of $34.21. Moreover, at the end of the last trading period, the closing price was at $55.99.
    • According to Deutsche Bank, the prior rating for AGCO Corp (NYSE:AGCO) was changed from Buy to Hold. In the third quarter, AGCO showed an EPS of $2.41, compared to $2.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $158.62 and a 52-week-low of $88.34. AGCO closed at $120.14 at the end of the last trading period.
    • Goldman Sachs downgraded the previous rating for Radius Health Inc (NASDAQ:RDUS) from Buy to Neutral. For the third quarter, Radius Health had an EPS of $0.32, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $26.16 and a 52-week-low of $7.39. Radius Health closed at $7.60 at the end of the last trading period.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Buy rating, Maxim Group initiated coverage on WISeKey International Holding Ltd (NASDAQ:WKEY). The price target seems to have been set at $11.00 for WISeKey Intl Hldg. The current stock performance of WISeKey Intl Hldg shows a 52-week-high of $22.40 and a 52-week-low of $4.24. Moreover, at the end of the last trading period, the closing price was at $4.75.
    • With a Speculative Buy rating, Benchmark initiated coverage on Spruce Biosciences Inc (NASDAQ:SPRB). The price target seems to have been set at $7.00 for Spruce Biosciences. Spruce Biosciences earned $0.49 in the third quarter, compared to $12.35 in the year-ago quarter. The stock has a 52-week-high of $28.49 and a 52-week-low of $2.25. At the end of the last trading period, Spruce Biosciences closed at $2.56.
    • Jefferies initiated coverage on SomaLogic Inc (NASDAQ:SLGC) with a Buy rating. The price target for SomaLogic is set to $16.00.
    • Truist Securities initiated coverage on Cyxtera Technologies Inc (NASDAQ:CYXT) with a Buy rating. The price target for Cyxtera Technologies is set to $15.00.
    • HC Wainwright & Co. initiated coverage on Delcath Systems Inc (NASDAQ:DCTH) with a Buy rating. The price target for Delcath Systems is set to $25.00. For the third quarter, Delcath Systems had an EPS of $0.94, compared to year-ago quarter EPS of $1.16. At the moment, the stock has a 52-week-high of $25.18 and a 52-week-low of $7.00. Delcath Systems closed at $8.02 at the end of the last trading period.
    • Benchmark initiated coverage on Aspen Aerogels Inc (NYSE:ASPN) with a Buy rating. The price target for Aspen Aerogels is set to $70.00. For the third quarter, Aspen Aerogels had an EPS of $0.35, compared to year-ago quarter EPS of $0.25. The current stock performance of Aspen Aerogels shows a 52-week-high of $65.99 and a 52-week-low of $14.24. Moreover, at the end of the last trading period, the closing price was at $55.78.
    • With an Outperform rating, Wolfe Research initiated coverage on Spirit Realty Capital Inc (NYSE:SRC). The price target seems to have been set at $57.00 for Spirit Realty Cap. For the third quarter, Spirit Realty Cap had an EPS of $0.84, compared to year-ago quarter EPS of $0.72. At the moment, the stock has a 52-week-high of $52.29 and a 52-week-low of $36.89. Spirit Realty Cap closed at $46.78 at the end of the last trading period.
    • With a Neutral rating, Goldman Sachs initiated coverage on Flywire Corp (NASDAQ:FLYW). The price target seems to have been set at $47.00 for Flywire. The current stock performance of Flywire shows a 52-week-high of $57.41 and a 52-week-low of $27.63. Moreover, at the end of the last trading period, the closing price was at $40.02.
    • With a Buy rating, Goldman Sachs initiated coverage on Paymentus Holdings Inc (NYSE:PAY). The price target seems to have been set at $41.00 for Paymentus Holdings. The current stock performance of Paymentus Holdings shows a 52-week-high of $39.23 and a 52-week-low of $22.53. Moreover, at the end of the last trading period, the closing price was at $27.26.
    • Goldman Sachs initiated coverage on Riskified Ltd (NYSE:RSKD) with a Sell rating. The price target for Riskified is set to $9.00.
    • With a Buy rating, Goldman Sachs initiated coverage on Global E Online Ltd (NASDAQ:GLBE). The price target seems to have been set at $89.00 for Global E Online. At the moment, the stock has a 52-week-high of $83.77 and a 52-week-low of $24.22. Global E Online closed at $62.00 at the end of the last trading period.
    • With an Overweight rating, JP Morgan initiated coverage on Cytokinetics Inc (NASDAQ:CYTK). The price target seems to have been set at $58.00 for Cytokinetics. Cytokinetics earned $0.95 in the third quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $42.87 and a 52-week-low of $16.81. At the end of the last trading period, Cytokinetics closed at $35.03.
    • DA Davidson initiated coverage on ironSource Ltd (NYSE:IS) with a Buy rating. The price target for ironSource is set to $11.00. The current stock performance of ironSource shows a 52-week-high of $13.14 and a 52-week-low of $7.56. Moreover, at the end of the last trading period, the closing price was at $8.30.
    • DA Davidson initiated coverage on AppLovin Corp (NASDAQ:APP) with a Buy rating. The price target for AppLovin is set to $125.00. The stock has a 52-week-high of $116.09 and a 52-week-low of $49.41. At the end of the last trading period, AppLovin closed at $90.78.
    • With a Buy rating, DA Davidson initiated coverage on European Sustainable Growth Acquisition Corp (NASDAQ:EUSG). The price target seems to have been set at $17.00 for European Sustainable. At the moment, the stock has a 52-week-high of $10.37 and a 52-week-low of $9.60. European Sustainable closed at $10.00 at the end of the last trading period.
    • Oppenheimer initiated coverage on BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) with an Outperform rating. The price target for BioCryst Pharmaceuticals is set to $16.00. In the third quarter, BioCryst Pharmaceuticals showed an EPS of $0.33, compared to $0.26 from the year-ago quarter. The current stock performance of BioCryst Pharmaceuticals shows a 52-week-high of $18.48 and a 52-week-low of $6.83. Moreover, at the end of the last trading period, the closing price was at $11.78.
    • With an Outperform rating, Oppenheimer initiated coverage on Pliant Therapeutics Inc (NASDAQ:PLRX). The price target seems to have been set at $40.00 for Pliant Therapeutics. For the third quarter, Pliant Therapeutics had an EPS of $0.75, compared to year-ago quarter EPS of $0.47. At the moment, the stock has a 52-week-high of $43.92 and a 52-week-low of $11.91. Pliant Therapeutics closed at $14.22 at the end of the last trading period.
    • With an Outperform rating, RBC Capital initiated coverage on Edwards Lifesciences Corp (NYSE:EW). The price target seems to have been set at $142.00 for Edwards Lifesciences. For the third quarter, Edwards Lifesciences had an EPS of $0.54, compared to year-ago quarter EPS of $0.51. The stock has a 52-week-high of $123.27 and a 52-week-low of $78.44. At the end of the last trading period, Edwards Lifesciences closed at $120.34.
    • RBC Capital initiated coverage on Medtronic PLC (NYSE:MDT) with an Outperform rating. The price target for Medtronic is set to $140.00. In the second quarter, Medtronic showed an EPS of $1.32, compared to $1.02 from the year-ago quarter. The current stock performance of Medtronic shows a 52-week-high of $135.89 and a 52-week-low of $105.02. Moreover, at the end of the last trading period, the closing price was at $112.81.
    • With an Outperform rating, RBC Capital initiated coverage on Boston Scientific Corp (NYSE:BSX). The price target seems to have been set at $51.00 for Boston Scientific. For the third quarter, Boston Scientific had an EPS of $0.41, compared to year-ago quarter EPS of $0.37. The stock has a 52-week-high of $46.28 and a 52-week-low of $33.42. At the end of the last trading period, Boston Scientific closed at $41.28.
    • RBC Capital initiated coverage on Abbott Laboratories (NYSE:ABT) with an Outperform rating. The price target for Abbott Laboratories is set to $146.00. Abbott Laboratories earned $1.40 in the third quarter, compared to $0.98 in the year-ago quarter. The stock has a 52-week-high of $134.08 and a 52-week-low of $105.32. At the end of the last trading period, Abbott Laboratories closed at $132.53.
    • With an Outperform rating, RBC Capital initiated coverage on Teleflex Inc (NYSE:TFX). The price target seems to have been set at $415.00 for Teleflex. Teleflex earned $3.51 in the third quarter, compared to $2.77 in the year-ago quarter. At the moment, the stock has a 52-week-high of $449.38 and a 52-week-low of $289.00. Teleflex closed at $320.35 at the end of the last trading period.
    • With an Outperform rating, RBC Capital initiated coverage on NuVasive Inc (NASDAQ:NUVA). The price target seems to have been set at $60.00 for NuVasive. For the third quarter, NuVasive had an EPS of $0.32, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $72.61 and a 52-week-low of $44.80. At the end of the last trading period, NuVasive closed at $49.92.
    • RBC Capital initiated coverage on Stryker Corp (NYSE:SYK) with a Sector Perform rating. The price target for Stryker is set to $278.00. For the third quarter, Stryker had an EPS of $2.20, compared to year-ago quarter EPS of $2.14. At the moment, the stock has a 52-week-high of $281.16 and a 52-week-low of $220.90. Stryker closed at $260.54 at the end of the last trading period.
    • With a Sector Perform rating, RBC Capital initiated coverage on Zimmer Biomet Holdings Inc (NYSE:ZBH). The price target seems to have been set at $140.00 for Zimmer Biomet Holdings. Zimmer Biomet Holdings earned $1.81 in the third quarter, compared to $1.81 in the year-ago quarter. At the moment, the stock has a 52-week-high of $180.36 and a 52-week-low of $119.55. Zimmer Biomet Holdings closed at $125.44 at the end of the last trading period.
    • UBS initiated coverage on U.S. Bancorp (NYSE:USB) with a Buy rating. The price target for U.S. Bancorp is set to $70.00. U.S. Bancorp earned $1.30 in the third quarter, compared to $0.99 in the year-ago quarter. The stock has a 52-week-high of $63.01 and a 52-week-low of $42.47. At the end of the last trading period, U.S. Bancorp closed at $57.21.
    • With a Buy rating, UBS initiated coverage on PNC Financial Services Group Inc (NYSE:PNC). The price target seems to have been set at $240.00 for PNC Financial Services Gr. For the third quarter, PNC Financial Services Gr had an EPS of $3.75, compared to year-ago quarter EPS of $3.39. The stock has a 52-week-high of $217.60 and a 52-week-low of $139.30. At the end of the last trading period, PNC Financial Services Gr closed at $200.73.

    See all analyst ratings initiations.

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $AGCO
    $APP
    $ARNC

    CompanyDatePrice TargetRatingAnalyst
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Medtronic plc.
    $MDT
    2/9/2026$121.00Hold → Buy
    Needham
    Peloton Interactive Inc.
    $PTON
    2/6/2026$8.00 → $6.00Market Perform
    Telsey Advisory Group
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Medtronic plc.
    $MDT
    2/3/2026$117.00Buy
    Citigroup
    Fiserv Inc.
    $FISV
    2/2/2026Buy → Neutral
    Northcoast
    More analyst ratings

    $ABT
    $AGCO
    $APP
    $ARNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Peloton downgraded by Argus

    Argus downgraded Peloton from Buy to Hold

    2/10/26 7:17:53 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $AGCO
    $APP
    $ARNC
    SEC Filings

    View All

    SEC Form FWP filed by Royal Caribbean Cruises Ltd.

    FWP - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Subject)

    2/12/26 5:08:47 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Paymentus Holdings Inc.

    SCHEDULE 13G/A - Paymentus Holdings, Inc. (0001841156) (Subject)

    2/12/26 4:22:45 PM ET
    $PAY
    Real Estate

    Twilio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TWILIO INC (0001447669) (Filer)

    2/12/26 4:10:16 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $AGCO
    $APP
    $ARNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Read Rory P bought $152 worth of shares (20 units at $7.60) and sold $996,726 worth of shares (165,858 units at $6.01), decreasing direct ownership by 10% to 1,506,270 units (SEC Form 4)

    4 - Sprinklr, Inc. (0001569345) (Issuer)

    2/9/26 5:00:05 PM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CHAIRMAN AND CEO Ford Robert B bought $2,013,967 worth of Common shares without par value (18,800 units at $107.13) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    1/26/26 8:02:24 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $AGCO
    $APP
    $ARNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Pujol Henry L was granted 11,357 shares and covered exercise/tax liability with 4,202 shares, increasing direct ownership by 97% to 14,509 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:07:03 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    President & CEO Liberty Jason T was granted 296,251 shares and covered exercise/tax liability with 111,299 shares, increasing direct ownership by 148% to 309,732 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:06:05 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SVP, CLO, Secretary & CCO Lake Robert Alexander was granted 30,510 shares and covered exercise/tax liability with 11,586 shares, increasing direct ownership by 97% to 38,449 units (SEC Form 4)

    4 - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Issuer)

    2/12/26 6:04:49 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $ABT
    $AGCO
    $APP
    $ARNC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-7) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 10/01/2024. Application Category: NDA, Application Number: 201848, Application Classification: REMS

    10/2/24 4:43:10 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    FDA Approval for HEPZATO issued to DELCATH SYSTEMS INC

    Submission status for DELCATH SYSTEMS INC's drug HEPZATO (SUPPL-3) with active ingredient MELPHALAN HYDROCHLORIDE has changed to 'Approval' on 05/22/2024. Application Category: NDA, Application Number: 201848, Application Classification: Labeling

    5/23/24 10:32:08 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care

    March 1, 2024 - FDA Roundup: March 1, 2024

    For Immediate Release: March 01, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a letter of enforcement discretion for certain qualified health claims regarding the consumption of yogurt and the reduced risk of type 2 diabetes. The letter states that the FDA does not intend to object to the use of these claims, provide

    3/1/24 4:00:21 PM ET
    $BSX
    Medical/Dental Instruments
    Health Care

    $ABT
    $AGCO
    $APP
    $ARNC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Royal Caribbean Group announces pricing of $1.25 billion senior unsecured notes due 2033 and $1.25 billion senior unsecured notes due 2038

    MIAMI, Feb. 12, 2026 /PRNewswire/ -- Royal Caribbean Cruises Ltd. (NYSE:RCL) (the "Company") today announced that it has priced a registered public offering of $1.25 billion aggregate principal amount of 4.750% senior unsecured notes due 2033 (the "2033 Notes") and $1.25 billion aggregate principal amount of 5.250% senior unsecured notes due 2038 (the "2038 Notes" and, together with the 2033 Notes, the "Notes"). The 2033 Notes will mature on May 15, 2033 and the 2038 Notes will mature on February 27, 2038. The Notes are expected to be issued on or around February 27, 2026, subject to the satisfaction of customary closing conditions.

    2/12/26 5:03:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    Twilio Announces Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $1.37 billion, up 14% reported and 12% organic year-over-year Full Year Revenue of $5.07 billion, up 14% reported and 13% organic year-over-year Fourth Quarter and Full Year GAAP Income from Operations of $57 million and $158 million, respectively Fourth Quarter and Full Year Non-GAAP Income from Operations of $256 million and $924 million, respectively Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, reported financial results for its fourth quarter and full year ended December 31, 2025. "2025 was one of the most balanced and successful years of execution in Twilio's his

    2/12/26 4:05:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $AGCO
    $APP
    $ARNC
    Leadership Updates

    Live Leadership Updates

    View All

    Martin Marietta Appoints George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary

    RALEIGH, N.C., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE:MLM) (Martin Marietta or the Company), a leading national supplier of aggregates and heavy building materials, today announced the appointment of George F. Schoen as Executive Vice President, General Counsel and Corporate Secretary, further strengthening the Company's leadership team as it executes its long-term strategic plan. Mr. Schoen will join the Company in March 2026. Mr. Schoen, who most recently served as Co-Chair of the Global Mergers and Acquisitions Practice at Cravath, Swaine & Moore LLP, is widely recognized as one of the nation's foremost M&A and corporate governance attorneys. He has adv

    2/11/26 4:15:00 PM ET
    $MLM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ABT
    $AGCO
    $APP
    $ARNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Torrid Holdings Inc.

    SC 13G - Torrid Holdings Inc. (0001792781) (Subject)

    12/12/24 6:06:52 PM ET
    $CURV
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Carrier Global Corporation

    SC 13D/A - CARRIER GLOBAL Corp (0001783180) (Subject)

    11/29/24 10:35:44 AM ET
    $CARR
    Industrial Machinery/Components
    Industrials

    $ABT
    $AGCO
    $APP
    $ARNC
    Financials

    Live finance-specific insights

    View All

    Twilio Announces Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $1.37 billion, up 14% reported and 12% organic year-over-year Full Year Revenue of $5.07 billion, up 14% reported and 13% organic year-over-year Fourth Quarter and Full Year GAAP Income from Operations of $57 million and $158 million, respectively Fourth Quarter and Full Year Non-GAAP Income from Operations of $256 million and $924 million, respectively Twilio (NYSE:TWLO), the customer engagement platform that drives real-time, personalized experiences for today's leading brands, reported financial results for its fourth quarter and full year ended December 31, 2025. "2025 was one of the most balanced and successful years of execution in Twilio's his

    2/12/26 4:05:00 PM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    Cytokinetics to Announce Fourth Quarter Results on February 24, 2026

    SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2026 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 PM Eastern Time to discuss financial results and provide business updates. The conference call will be simultaneously webcast and can be accessed from the Investors & Media section of Cytokinetics' website at www.cytokinetics.com or directly at the following link: Cytokinetics Q4 2025 Earnings Conference Call. An archived replay of the webcast will be available via Cytokinetics'

    2/12/26 4:00:00 PM ET
    $CYTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call

    Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on February 26, 2026, at 8:30 AM Eastern Time to discuss results for its fourth quarter and full year ended December 31, 2025. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call. Event Date: Thursday, February 26, 2026 Time: 8:30 AM Eastern Time Participant Numbers: Toll Free: 1-877-407-3982 International: 1-201-493-6780 Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1747469&tp_key=15ec7bd15c A replay of the w

    2/12/26 8:00:00 AM ET
    $DCTH
    Medical/Dental Instruments
    Health Care